P38 MAP kinase inhibitors

Details for Australian Patent Application No. 2009326149 (hide)

Owner Respivert Limited

Inventors Ito, Kazuhiro; Strong, Peter; Rapeport, William Garth; Murray, Peter John; King-Underwood, John; Williams, Jonathan Gareth; Onions, Stuart Thomas; Hirst, Simon Christopher; Taddei, David Michel Adrien; Charron, Catherine Elisabeth

Agent Shelston IP

Pub. Number AU-A-2009326149

PCT Pub. Number WO2010/067131

Priority 61/166,594 03.04.09 US; 0822609.4 11.12.08 GB; 0912470.2 17.07.09 GB

Filing date 11 December 2009

Wipo publication date 17 June 2010

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/415 (2006.01) - 1,2-Diazoles

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

9 June 2011 PCT application entered the National Phase

  PCT publication WO2010/067131 Priority application(s): WO2010/067131

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009326167-Rifaximin complexes

2009326148-P38 MAP kinase inhibitors